HCPCS Level IIdrugActive
J9263
Oxaliplatin
BETOS: O1D
Effective: 2018-01-01
Referenced in 1 policies
Description
Injection, oxaliplatin, 0.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Oxaliplatin
Manufacturer
Teva Parenteral Medicines, Inc.
HCPCS Dosage
0.5 MG
Billing Units
100.0000
42
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.